/CRTSF

CRTSF Stock - Chr. Hansen Holding A/S

Q: What is the analyst price target for CRTSF?

Analyst price target information is not currently available for CRTSF.

Q: What is CRTSF's market cap?

Market capitalization information is not currently available for CRTSF.

Basic Materials|Chemicals - Specialty|OTC

$79.30+5.73%

+$4.30 (+5.73%) • Nov 30

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $87.23

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CRTSF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.33

52W High$79.54

52W Low$61.43

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$1.33B	$1.22B	$1.08B	$970.00M	$1.16B
Gross Profit	$723.30M	$676.50M	$613.40M	$584.00M	$650.00M
Gross Margin	54.2%	55.5%	56.9%	60.2%	56.0%
Operating Income	$358.80M	$320.90M	$276.20M	$313.00M	$340.90M
Net Income	$227.00M	$225.10M	$845.20M	$245.00M	$250.20M
Net Margin	17.0%	18.5%	78.4%	25.3%	21.5%
EPS	$1.72	$1.71	$6.42	$1.86	$1.90

Company Overview

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

Visit Website

Earnings History & Surprises

CRTSF

Beat Rate

14%

Last 14 quarters

Avg Surprise

-3.6%

EPS vs Estimate

Beats / Misses

2/9

3 met exactly

Latest EPS

$0.49

Q3 2023

EPS Surprise History

Q4 21

+0.2%

$0.40vs$0.40

Q1 22

+3.2%

$0.48vs$0.47

Q2 22

-3.0%

$0.48vs$0.50

Q3 22

-4.7%

$0.46vs$0.49

Q4 22

-8.9%

$0.40vs$0.44

Q1 23

-2.6%

$0.47vs$0.48

Q2 23

-9.8%

$0.48vs$0.54

Q3 23

-12.5%

$0.49vs$0.56

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Aug 31, 2023	$0.56	$0.49	-12.5%	✗ MISS
Q2 2023	May 31, 2023	$0.54	$0.48	-9.8%	✗ MISS
Q1 2023	Feb 28, 2023	$0.48	$0.47	-2.6%	✗ MISS
Q4 2022	Nov 30, 2022	$0.44	$0.40	-8.9%	✗ MISS
Q3 2022	Aug 31, 2022	$0.49	$0.46	-4.7%	✗ MISS
Q2 2022	May 31, 2022	$0.50	$0.48	-3.0%	✗ MISS
Q1 2022	Feb 28, 2022	$0.47	$0.48	+3.2%	✓ BEAT
Q4 2021	Nov 30, 2021	$0.40	$0.40	+0.2%	✓ BEAT
Q3 2021	Aug 31, 2021	—	$0.62	—	—
Q2 2021	May 31, 2021	—	$6.28	—	—
Q1 2021	Feb 28, 2021	—	$0.50	—	—
Q4 2020	Nov 30, 2020	—	$0.38	—	—
Q3 2020	Aug 31, 2020	—	$0.59	—	—
Q2 2020	May 31, 2020	—	$0.57	—	—
Q2 2020	Apr 16, 2020	$0.49	$0.49	0.0%	= MET
Q1 2020	Jan 15, 2020	$0.43	$0.43	0.0%	= MET
Q4 2019	Oct 10, 2019	$0.63	$0.63	0.0%	= MET
Q2 2019	Jun 26, 2019	$0.60	$0.57	-5.6%	✗ MISS
Q2 2019	Apr 3, 2019	$0.51	$0.49	-2.2%	✗ MISS
Q1 2019	Jan 17, 2019	$0.47	$0.44	-4.9%	✗ MISS

Frequently Asked Questions about CRTSF

What is CRTSF's current stock price?

Chr. Hansen Holding A/S (CRTSF) is currently trading at $79.30 per share. The stock has moved +5.73% today.

What is the analyst price target for CRTSF?

No analyst price targets are currently available for this stock.

What sector is Chr. Hansen Holding A/S in?

Chr. Hansen Holding A/S operates in the Basic Materials sector, specifically within the Chemicals - Specialty industry. The company is traded on the OTC exchange.

What is CRTSF's market cap?

Chr. Hansen Holding A/S has a market capitalization of $10.44 billion, making it a large-cap company.

Does CRTSF pay dividends?

No, Chr. Hansen Holding A/S does not currently pay a dividend to shareholders.